Our world-class experts. Your child’s care team.
Exceptional science. Innovative cures.
Science & medicine news
-
St. Jude trial identifies a medulloblastoma subset that requires less aggressive therapy
For a subset of the youngest patients with the brain tumor medulloblastoma, less aggressive therapy was associated with better long-term survival.
-
‘Lone wolf’ protein offers new pathway to cancer treatments
The protein called BOK offers another target for drugs to selectively trigger apoptosis.
-
St. Jude named the World Health Organization’s first Collaborating Centre for Childhood Cancer
St. Jude is partnering with WHO to develop strategies that strengthen the global resources, organization and planning needed to identify and treat pediatric cancer.
-
Genetic counseling and testing proposed for patients with the brain tumor medulloblastoma
Researchers created the first genetic screening guidelines for medulloblastoma patients after identifying gene variations that make carriers susceptible.
-
Research pinpoints viral mutation that would trigger resistance to new anti-influenza drugs
Using combination therapy for flu, a new class of drug offers potential for multi-drug therapy and possibly improved influenza-fighting drugs.
-
Discovery adds to evidence that some children are predisposed to develop leukemia
A family’s history of childhood leukemia leads to the discovery of a fourth gene (IKZF1) that predisposes carriers to pediatric acute lymphoblastic leukemia.
